Davidson Michael H.'s Form 4 filing
NewAmsterdam Pharma Co N.V. (NAMS) · filed Mar 28, 2025
- Accession no.
- 0000950170-25-046934
- Filed
- Mar 28, 2025
- Trade date
- Mar 26, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davidson Michael H.CIK 0001573785 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | Ordinary Shares | AGrant or awardAcquired | +30,992 | $0.00 | $0 | 364,305 | Direct | |
| Mar 26, 2025 | Ordinary Shares | MOption exerciseAcquired | +38,394 | $0.00 | $0 | 402,699 | Direct | |
| Mar 26, 2025 | Ordinary Shares | SSaleDisposed | −12,258 | – | – | 390,441 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | Ordinary Shares | AGrant or awardAcquired | +38,394 | – | – | 38,394 | Direct | |
| Mar 26, 2025 | Ordinary Shares | MOption exerciseDisposed | −38,394 | – | – | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.